Literature DB >> 7391259

Foreperiod effect on time estimation and simple reaction time in schizophrenia.

S M Suchoon, R Kersey.   

Abstract

Compared effects of foreperiod (FP) duration on time estimation (TE) and reaction time (RT). There was no difference between schizophrenics (N = 20) and nonschizophrenics (N = 20) with respect to the effect of FP duration or with respect to the effect of change in FP duration. Prior information about FP duration nullified these two effects on schizophrenics' TE and had a detrimental effect on their RT. Alcoholics' TE and RT were affected little by such prior information. Suppression of preparation by expectany was shown to be a possible characteristic of schizophrenia.

Entities:  

Mesh:

Year:  1980        PMID: 7391259     DOI: 10.1002/1097-4679(198001)36:1<94::aid-jclp2270360105>3.0.co;2-0

Source DB:  PubMed          Journal:  J Clin Psychol        ISSN: 0021-9762


  12 in total

1.  Immune checkpoint inhibitors-associated pericardial disease: a systematic review of case reports.

Authors:  Alessandro Inno; Nicola Maurea; Giulio Metro; Andreina Carbone; Antonio Russo; Stefania Gori
Journal:  Cancer Immunol Immunother       Date:  2021-04-20       Impact factor: 6.968

Review 2.  Abdominal CT manifestations of adverse events to immunotherapy: a primer for radiologists.

Authors:  Ali Pourvaziri; Anushri Parakh; Pierpaolo Biondetti; Dushyant Sahani; Avinash Kambadakone
Journal:  Abdom Radiol (NY)       Date:  2020-09

3.  Lipid Metabolism and Immune Checkpoints.

Authors:  Qianjin Liao; Yujuan Zhou; Longzheng Xia; Deliang Cao
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 4.  Programmed death ligand 1 signals in cancer cells.

Authors:  Anand V R Kornepati; Ratna K Vadlamudi; Tyler J Curiel
Journal:  Nat Rev Cancer       Date:  2022-01-14       Impact factor: 60.716

5.  Conjugation of glucosylated polymer chains to checkpoint blockade antibodies augments their efficacy and specificity for glioblastoma.

Authors:  Tao Yang; Yuki Mochida; Xueying Liu; Hang Zhou; Jinbing Xie; Yasutaka Anraku; Hiroaki Kinoh; Horacio Cabral; Kazunori Kataoka
Journal:  Nat Biomed Eng       Date:  2021-10-11       Impact factor: 25.671

Review 6.  Immunotherapy for advanced thyroid cancers - rationale, current advances and future strategies.

Authors:  Jena D French
Journal:  Nat Rev Endocrinol       Date:  2020-08-24       Impact factor: 43.330

Review 7.  Dilemma and Challenge of Immunotherapy for Pancreatic Cancer.

Authors:  Jia Wu; Jianting Cai
Journal:  Dig Dis Sci       Date:  2020-03-05       Impact factor: 3.199

8.  Activation of STING inhibits cervical cancer tumor growth through enhancing the anti-tumor immune response.

Authors:  Fan Shi; Jin Su; Juan Wang; Zi Liu; Tao Wang
Journal:  Mol Cell Biochem       Date:  2020-11-03       Impact factor: 3.396

9.  Knockout of immunotherapy prognostic marker genes eliminates the effect of the anti-PD-1 treatment.

Authors:  Naixue Yang; Fansen Ji; Liqing Cheng; Jingzhe Lu; Xiaofeng Sun; Xin Lin; Xun Lan
Journal:  NPJ Precis Oncol       Date:  2021-05-07

Review 10.  Metabolic networks in mutant KRAS-driven tumours: tissue specificities and the microenvironment.

Authors:  Samuel A Kerk; Thales Papagiannakopoulos; Yatrik M Shah; Costas A Lyssiotis
Journal:  Nat Rev Cancer       Date:  2021-07-09       Impact factor: 69.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.